The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 12×
“Irrespective of subunit composition, all (NR1/NR2) species of NMDA receptor reveal voltage-dependent blockade by Mg2+ which binds to (multiple) sites in the ion channel, restricting the flux of Ca2+ (Dingledine et al. 1999; Cull-Candy et al. 2001).”
BackgroundInfluentialMemantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · cited 1×
“This phenomenon is seen both in rodents and in man and resembles psychotic states (Breier et al. 1997; Kegeles et al. 2000; Balla et al. 2001a,b; Javitt et al. 2004a).”
BackgroundMice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Schell, M. J., Molliver, M. E., & Snyder, S. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3948 · Cited by 832
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · cited 2×
“same one as zinc—and decreases in its levels in schizophrenia were interpreted as contributing to reduced activity at these sites (Do et al. 2000).”
BackgroundSerotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529 · cited 2×
“…pathways and consequent recruitment of corticolimbic populations of 5-HT2A receptors, effected independents of NMDA receptors (Millan et al. 1999; Aghajanian and Marek 2000) 3) Disruption of striatothalamic filtering of sensory input into the cortex (Carlsson et al. 2001) 4) A generalized…”
BackgroundNMDA-dependent modulation of CA1 local circuit inhibition
Grunze, H., Rainnie, D., Hasselmo, M., Barkai, E., Hearn, E., McCarley, R., & Greene, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02034.1996 · Cited by 467 · cited 1×
“…and asparate shifts the balance to postsynaptic excitation since NAAG has low intrinsic activity at NMDA receptors sites and behaves as an antagonist relative to glycine and D-serine, for example, in the CA1 region of the hippocampus (Grunze et al. 1996; Coyle 1997; Bergeron et al. 2005).”
BackgroundKapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459 · cited 2×
“Finally, direct interactions of PCP and ketamine with sites other than NMDA receptors (including monoaminergic receptors and transporters, sigma binding sites and ion channels) contribute to their functional and, possibly, pro-psychotic properties (see point 2 above) (Steinpreis 1996; Millan et al. 1999; Kapur and See…”
BackgroundBeyond the role of glutamate as a neurotransmitter
Nedergaard, M., Takano, T., & Hansen, A. J. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn916 · Cited by 450
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Glutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408 · cited 1×
“…in the control of cognition, mood and motor function, which are disturbed in schizophrenia (Schmidt and Kretschmer 1997; Danysz and Parsons 1998; Paul and Skolnick 2003); (3) evidence that a dysfunction of glutamatergic transmission is implicated in psychotic states (Meador-Woodruff and Healy…”
BackgroundTseng, K. Y., & O'Donnell, P. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1021-04.2004 · Cited by 402
The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses
Garcia, R. A. G., Vasudevan, K., & Buonanno, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3596 · Cited by 278
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G., & Javitt, D. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00707-8 · Cited by 222 · cited 2×
“…findings were documented for the newer antipsychotics, olanzapine and risperidone: adjunctive glycine (0.8 mg/kg/day) improved negative and, less markedly, cognitive and positive symptoms in treatment-refractory subjects, while also ameliorating tardive dyskinesia (Heresco-Levy et al. 2004).”
BackgroundInfluentialTerada, T., & Inui, K.-I. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489153 · Cited by 177 · cited 1×
“Astrocytes do not only cleave NAAG: they also take it up via a proton-coupled di/tripeptide transporter termed “PEPT2” (Fujita et al. 2004; Terada and Inui 2004).”
BackgroundMatute, C., Melone, M., Vallejo‐Illarramendi, A., & Conti, F. (2005) · Glia · doi:10.1002/glia.20119 · Cited by 129
Modulating sensory gating in healthy volunteers
Oranje, B., Gispen-de Wied, C. C., Verbaten, M. N., & Kahn, R. S. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01377-x · Cited by 98
Cited by
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Self-citationMechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia
Horacek, J., Bubenikova-Valesova, V., Kopecek, M., Palenicek, T., Dockery, C., Mohr, P., & H??schl, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00004 · Cited by 461
Vita, A., De Peri, L., Deste, G., & Sacchetti, E. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.116 · Cited by 453
Metadata
- Authors
- Millan, M. J.
- Venue
- Psychopharmacology
- Published
- 2005-03-10
- Volume
- 179
- Issue
- 1
- Pages
- 30-53
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2088790808
- Cited by
- 221
- References
- 20
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.